David A. Siegel Concert Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $511,252 - $687,952	-117,800 Reduced 24.12%	370,500 $2.16 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $1.45 Million - $2.45 Million	340,700 Added 230.83%	488,300 $3.27 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $229,599 - $521,520	82,000 Added 125.0%	147,600 $621,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $81,354 - $117,412	-29,800 Reduced 31.24%	65,600 $221,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $123,471 - $193,698	45,900 Added 92.73%	95,400 $301,000
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.15 $10,144 - $13,280	3,200 Added 6.91%	49,500 $162,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $127,049 - $176,588	-33,700 Reduced 42.13%	46,300 $195,000
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $64,152 - $172,524	-13,200 Reduced 14.16%	80,000 $399,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $75,840 - $102,720	-8,000 Reduced 7.91%	93,200 $1.18 Million
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $192,404 - $240,117	-22,192 Reduced 17.98%	101,200 $994,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $3,837 - $5,667	492 Added 0.4%	123,392 $1.23 Million
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $48,438 - $106,029	8,100 Added 7.06%	122,900 $1.09 Million
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $34,260 - $55,320	6,000 Added 5.51%	114,800 $1.06 Million
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $25,872 - $54,340	4,400 Added 4.21%	108,800 $640,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $422,912 - $587,776	44,800 Added 75.17%	104,400 $1.25 Million
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $106,216 - $154,352	-8,800 Reduced 12.87%	59,600 $719,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $52,875 - $75,999	-4,700 Reduced 6.43%	68,400 $858,000
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $53,844 - $75,096	4,200 Added 6.1%	73,100 $1.09 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $420,749 - $541,500	25,000 Added 56.95%	68,900 $1.16 Million
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $268,167 - $390,682	-13,938 Reduced 24.1%	43,900 $1.01 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $807,418 - $1.68 Million	57,838	57,838 $1.5 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account